No Data
H.C. Wainwright Initiates Vera Therapeutics(VERA.US) With Buy Rating, Announces Target Price $75
Vera Therapeutics Coverage Assumed by HC Wainwright & Co. at Buy
Vera Therapeutics Price Target Announced at $75.00/Share by HC Wainwright & Co.
Analysts Offer Insights on Healthcare Companies: Baxter International (BAX) and Vera Therapeutics (VERA)
Kidney Disease-Focused Vera Therapeutics Concludes Enrollment In Pivotal Study, Targets 2026 Commercial Launch
Guggenheim Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $61